Deoxyspergualin (NKT-01)

Deoxyspergualin · Nippon Kayaku Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Deoxyspergualin (NKT-01), covering 2017-01-10 to 2017-01-10. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy on Deoxyspergualin (NKT-01) in Patients With Lupus Nephritis [Phase 1, Phase 2]